Confronting Current Controlled Substance Diversion Issues – How Drugs Are “Lost” in Transit and Strategies to Mitigate Risk Throughout the Supply Chain
Home Study Webinar
$20 Activity Fee
Topic Designator: 03 – Law | Credit: 1.5 contact hours Available through May 6, 2029
As detailed in NABP Resolution 121-1-25, drugs lost in transit may cause delays or interruptions in patient drug therapy, adversely affecting patient health. Further, diverted drugs may reenter the supply chain through the gray market and pose additional risks to public health. Participants will learn about possible entry points for diverted controlled drugs and regulatory strategies to identify gaps and evaluate reporting requirements. In addition, participants will find out about the latest anti-diversion initiatives used at the pharmacy level to identify and prevent supply chain diversion.
This home study webinar is a recording of the live activity that was held on May 14, 2026, and was sponsored by Walgreens.
Presenters
Charles “Chuck” Forsaith
Vice President of Pharmaceutical Cargo Security Coalition, Healthcare Distribution Alliance
Chuck Forsaith is the vice president of the Healthcare Distribution Alliance’s Pharmaceutical Cargo Security Coalition. The Coalition, which has over 2,000 active members, monitors the security of pharmaceutical goods in transit and in storage worldwide. Chuck has been involved in the supply chain security discipline for more than 24 years, with experience lecturing on Supply Chain and Site Security for organizations such as FDA, Department of Homeland Security, CIA, FBI, and DEA.
Matthew Strait
Principal, Controlled Substance Strategies, LLC
Matthew Strait is a recognized authority on controlled substance regulation with over 25 years of experience in diversion and congressional affairs at DEA. He has drafted federal legislation, led quota modernization, and advised Congress, the UN, national litigation teams, and private organizations on drug regulation and enforcement. He is also one of the few scientists to be selected for the federal government’s Senior Executive Service. Matthew was educated at MIT, the University of Notre Dame, and Virginia Tech, and he holds a TS/SCI, or TS-SCI, security clearance.
Michael Karnbach, PharmD
Director, Georgia Drugs and Narcotics Age
Michael Karnbach is the director of the Georgia Drugs and Narcotics Agency. In this role, he leads the state agency that is responsible for enforcing the laws, rules, and regulations of controlled substances, dangerous drugs, and pharmacy practice. Michael served as the agency’s deputy director for six years and as a special agent for 14 years. Michael has practiced and held leadership roles in a variety of pharmacy settings. He earned his doctorate in pharmacy from Mercer University School of Pharmacy.
